Frontlight ResearchEarly access
Huntington's disease trials in United Kingdom
6 of 9 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
- Where
- Birmingham, Cambridge, Cardiff, Glasgow, Greater Manchester, London, Oxford, Plymouth
- Age
- 25 years to 70 years
- People
- 66 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT06585449 - Phase 1Taking peopleA First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
- Where
- Birmingham, Cardiff, Oxford
- Age
- 21 years to 70 years
- People
- 32 worldwide
- Run by
- Sarepta Therapeutics, Inc.
See details and how to joinNCT07536061 - Phase 2/3Taking peopleStudy to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
- Where
- London, Motherwell
- Age
- 25 years and over
- People
- 400 worldwide
- Run by
- Skyhawk Therapeutics, Inc.
See details and how to joinNCT07378644 · EU 2025-522263-14-00 - Phase 3Taking peoplePridopidine Phase 3 Study in Huntington's Disease
- Where
- Aberdeen, Birmingham, Cardiff, Liverpool, Newcastle upon Tyne
- Age
- 23 years to 65 years
- People
- 400 worldwide
- Run by
- Prilenia
See details and how to joinNCT07609108 · EU 2026-526093-16-00 - Phase 3Taking peopleA Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- Where
- Aberdeen, Cambridge, Cardiff, Exeter, Glasgow, Leeds, London, Oxford, Southampton
- Age
- 21 years to 70 years
- People
- 770 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07326709 · EU 2025-522227-99-00 - Phase 1/2Taking peopleA Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
- Where
- London, Oxford
- Age
- 25 years to 60 years
- People
- 68 worldwide
- Run by
- Vico Therapeutics B. V.
See details and how to joinNCT05822908 · EU 2024-514328-18-00